Zusammenfassende Kommentierung der Übersicht von Volpe M, Int J Clin Pract 2008 - Mikroalbuminurie-Screening bei Patienten mit Hypertonie: Empfehlungen für die klinische Praxis

Literatur

• 01 Volpe M . Microalbuminuria screening in patients with hypertension: recommendations for clinical practice.  Int J Clin Pract. 2008;  62 97-108
• 02 Bramlage P . Pittrow D . Lehnert H . et al . Frequency of albuminuria in primary care: a cross-sectional study.  Eur J Cardiovasc Prev Rehabil. 2007;  14 107-113
• 03 Klausen KP . Scharling H . Jensen G . Jensen JS . New definition of microalbuminuria in hypertensive subjects: association with incident coronary heart disease and death.  Hypertension. 2005;  46 33-37
• 04 Chaturvedi N . Sjoelie AK . Svensson A . The Diabetic Retinopathy Candesartan Trials (DIRECT) Programme, rationale and study design.  J Renin Angiotensin Aldosterone Syst. 2002;  3 255-261
• 05 Parving HH . Lehnert H . Brochner-Mortensen J . et al . The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes.  N Engl J Med. 2001;  345 870-878
• 06 Morgensen CE . Neldam S . Tikkanen I . et al . Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study.  BMJ. 2000;  321 1440-1444